Literature DB >> 19040483

Liver transplantations with donors aged 60 years and above: the low liver damage strategy.

Matteo Ravaioli1, Gian Luca Grazi, Matteo Cescon, Alessandro Cucchetti, Giorgio Ercolani, Michelangelo Fiorentino, Ilaria Panzini, Marco Vivarelli, Giovanni Ramacciato, Massimo Del Gaudio, Gaetano Vetrone, Matteo Zanello, Alessandro Dazzi, Chiara Zanfi, Paolo Di Gioia, Valentina Bertuzzo, Augusto Lauro, Cristina Morelli, Antonio Daniele Pinna.   

Abstract

According to transplant registries, grafts from elderly donors have lower survival rates. During 1999-2005, we evaluated the outcomes of 89 patients who received a liver from a donor aged > or = 60 years and managed with the low liver-damage strategy (LLDS), based on the preoperative donor liver biopsy and the shortest possible ischemia time (group D > or = 60-LLDS). Group D > or = 60-LLDS was compared with 198 matched recipients, whose grafts were not managed with this strategy (89 donors < 60 years, group D < 60-no-LLDS and 89 donors aged > or =60 years, group D > or = 60-no-LLDS). In the donors proposed from the age group of > or =60 years, the number of donors rejected decreased during the study period and the LLDS was found to be responsible for this in a significant manner (47% vs. 60%, respectively P < 0.01). Among the recipients transplanted, the clinical features (age, gender, viral infection, child and model for end-stage liver disease score) were comparable among groups, but group D > or = 60-LLDS had a lower mean ischemia time: 415 +/- 106 min vs. 465 +/- 111 (D < 60-no-LLDS), P < 0.05 and vs. 476 +/- 94 (D > or = 60-no-LLDS), P < 0.05. After a median follow-up of 3 years, the 1- and 3-year graft survival rates of group D > or = 60-LLDS (84% and 76%) were comparable with group D < 60-no-LLDS (89% and 76%) and were significantly higher than group D > or = 60-no-LLDS (71% and 54%), P < 0.005. In conclusion, the LLDS optimized the use of livers from elderly donors.

Entities:  

Mesh:

Year:  2008        PMID: 19040483     DOI: 10.1111/j.1432-2277.2008.00812.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  8 in total

Review 1.  Using old liver grafts for liver transplantation: where are the limits?

Authors:  Carlos Jiménez-Romero; Oscar Caso Maestro; Félix Cambra Molero; Iago Justo Alonso; Cristina Alegre Torrado; Alejandro Manrique Municio; Jorge Calvo Pulido; Carmelo Loinaz Segurola; Enrique Moreno González
Journal:  World J Gastroenterol       Date:  2014-08-21       Impact factor: 5.742

2.  Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years.

Authors:  Carlos Jiménez-Romero; Marta Clemares-Lama; Alejandro Manrique-Municio; Alvaro García-Sesma; Jorge Calvo-Pulido; Enrique Moreno-González
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

Review 3.  Expanded criteria donors.

Authors:  Sandy Feng; Jennifer C Lai
Journal:  Clin Liver Dis       Date:  2014-08       Impact factor: 6.126

4.  The Kupffer Cell Number Affects the Outcome of Living Donor Liver Transplantation from Elderly Donors.

Authors:  Masaaki Hidaka; Susumu Eguchi; Mitsuhisa Takatsuki; Akihiko Soyama; Shinichiro Ono; Tomohiko Adachi; Koji Natsuda; Tota Kugiyama; Takanobu Hara; Satomi Okada; Hajime Imamura; Satoshi Miuma; Hisamitsu Miyaaki
Journal:  Transplant Direct       Date:  2016-07-22

5.  Octogenarian liver grafts: Is their use for transplant currently justified?

Authors:  Carlos Jiménez-Romero; Felix Cambra; Oscar Caso; Alejandro Manrique; Jorge Calvo; Alejandro Marcacuzco; Paula Rioja; David Lora; Iago Justo
Journal:  World J Gastroenterol       Date:  2017-05-07       Impact factor: 5.742

6.  Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants.

Authors:  Miriam Capri; Fabiola Olivieri; Catia Lanzarini; Daniel Remondini; Vincenzo Borelli; Raffaella Lazzarini; Laura Graciotti; Maria Cristina Albertini; Elena Bellavista; Aurelia Santoro; Fiammetta Biondi; Enrico Tagliafico; Elena Tenedini; Cristina Morsiani; Grazia Pizza; Francesco Vasuri; Antonietta D'Errico; Alessandro Dazzi; Sara Pellegrini; Alessandra Magenta; Marco D'Agostino; Maurizio C Capogrossi; Matteo Cescon; Maria Rita Rippo; Antonio Domenico Procopio; Claudio Franceschi; Gian Luca Grazi
Journal:  Aging Cell       Date:  2016-12-20       Impact factor: 9.304

7.  Results of liver transplantation with donors older than 80 years: a case control study.

Authors:  Francisco Javier León Díaz; José Luis Fernández Aguilar; Belinda Sánchez Pérez; Custodia Montiel Casado; José Manuel Aranda Narváez; José Antonio Pérez Daga; Miguel Ángel Suárez Muñoz; Julio Santoyo Santoyo
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017

8.  Hypothermic Oxygenated New Machine Perfusion System in Liver and Kidney Transplantation of Extended Criteria Donors:First Italian Clinical Trial.

Authors:  Matteo Ravaioli; Vanessa De Pace; Andrea Angeletti; Giorgia Comai; Francesco Vasuri; Maurizio Baldassarre; Lorenzo Maroni; Federica Odaldi; Guido Fallani; Paolo Caraceni; Giuliana Germinario; Chiara Donadei; Deborah Malvi; Massimo Del Gaudio; Valentina Rosa Bertuzzo; Antonio Siniscalchi; Vito Marco Ranieri; Antonietta D'Errico; Gianandrea Pasquinelli; Maria Cristina Morelli; Antonio Daniele Pinna; Matteo Cescon; Gaetano La Manna
Journal:  Sci Rep       Date:  2020-04-08       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.